Novo Nordisk Stock Soars on New Weight-Loss Drug Results
Novo Nordisk stock jumped Friday after the Danish drugmaker announced new data for a new weight-loss drug which appeared to ...
Novo Nordisk Shares Surge on New Obesity Drug Results
Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients ...
Novo Nordisk Shares Surge on New Obesity Drug Results — Update
The trial tested amycretin in its injectable form, but Novo Nordisk is also separately developing the drug in pill form. Investors cheered an early trial of the pill early last year that showed weight ...
Crackdown on Ozempic, Wegovy Hits Thousands In Colorado
Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.
Medscape1h
A Guide for Discussing GLP-1s as Obesity Treatments
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
Ozempic’s health benefits keep growing, but are the risks worth it?
Join Fox News for access to this content Plus special access to select articles and other premium content with your account - ...
The New York Times22h
Trump Plans to Abandon Clean Energy. Can He Do It?
For more audio journalism and storytelling, download New York Times Audio, a new iOS app available for news subscribers. Hosted by Sabrina Tavernise Featuring Coral Davenport Produced by Rob ...